Figures & data
Figure 1. Comparison of aspirin with other caloric-restriction mimetics. (A). Caloric-restriction mimetics may directly inhibit acetyltransferases, deplete acetyl coenzyme A (AcCoA) or activate deacetylases to stimulate protein deacetylation and consequent autophagy induction. (B) Salicylate generated from its prodrug, aspirin, directly inhibits the acetyltransferase activity of EP300, thus acting as a class I caloric-restriction mimetic to induce protein deacetylation and autophagy.
![Figure 1. Comparison of aspirin with other caloric-restriction mimetics. (A). Caloric-restriction mimetics may directly inhibit acetyltransferases, deplete acetyl coenzyme A (AcCoA) or activate deacetylases to stimulate protein deacetylation and consequent autophagy induction. (B) Salicylate generated from its prodrug, aspirin, directly inhibits the acetyltransferase activity of EP300, thus acting as a class I caloric-restriction mimetic to induce protein deacetylation and autophagy.](/cms/asset/aaa4c9b9-744b-46e4-b255-e6af6ee61596/kaup_a_1454810_f0001_c.jpg)